Sign In
Buy LLY
$1,131.42
+6.04 (+0.537%)
At Close: Jun 05, 2026
Eli Lilly Stock Surges on Demand for Weight-Loss Drugs
12:08pm, Tuesday, 30'th Apr 2024
Eli Lilly beat earnings expectations for the first quarter and raised its outlook for the year.
Why Eli Lilly Stock Is Jumping Today
11:26am, Tuesday, 30'th Apr 2024
Lilly missed Wall Street's revenue estimate for the first quarter. However, the drugmaker easily beat the consensus Q1 earnings estimate.
Lilly (LLY) Reports Q1 Earnings: What Key Metrics Have to Say
10:35am, Tuesday, 30'th Apr 2024
The headline numbers for Lilly (LLY) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates a
Eli Lilly Stock Surges as Weight Loss Drugs Continue to Fuel Growth
10:21am, Tuesday, 30'th Apr 2024
Eli Lilly (LLY) stock jumped in early trading Tuesday after the drugmaker reported first-quarter earnings that beat analysts' expectations and raised its guidance thanks to continued high demand for t
Eli Lilly (LLY) Tops Q1 Earnings Estimates
08:56am, Tuesday, 30'th Apr 2024
Eli Lilly (LLY) came out with quarterly earnings of $2.58 per share, beating the Zacks Consensus Estimate of $2.53 per share. This compares to earnings of $1.62 per share a year ago.
Dow Jones Today: Stock Futures Slip; Eli Lilly Soars on Earnings
08:55am, Tuesday, 30'th Apr 2024
U.S. stock futures ticked lower in premarket trading on Tuesday as earnings reports from consumer giants continued to roll in and the Federal Reserve began its two-day policy meeting.
Eli Lilly CEO on weight loss drugs outlook: Our top priority is making more product
08:30am, Tuesday, 30'th Apr 2024
Eli Lilly CEO David Ricks joins 'Squawk Box' to discuss the company's quarterly earnings results, the company's weight loss drugs, growth outlook, and more.
Mounjaro drives Eli Lilly sales skyward, shares near all-time high
08:22am, Tuesday, 30'th Apr 2024
Eli Lilly and Co (NYSE:LLY)'s weight loss medication Mounjaro drove impressive first-quarter earnings results for the US pharmaceuticals megacap. Mounjaro generated worldwide revenue of $1.81 billion
Eli Lilly Stock Jumps After Earnings Beat. Weight-Loss Drugs Are Driving Gains.
07:08am, Tuesday, 30'th Apr 2024
The pharmaceutical company reported adjusted earnings of $2.58 a share for the first quarter of 2024, up 59% from the same period a year earlier. Revenue rose 26% to $8.77 billion.
Eli Lilly's stock jumps as first-quarter profit tops estimates amid strong sales of Mounjaro, Zepbound
07:01am, Tuesday, 30'th Apr 2024
Eli Lilly & Co. shares gained more than 5% premarket on Tuesday after the company reported first-quarter profit that topped analyst expectations amid strong sales of diabetes drug Mounjaro and weight-
Earnings Exchange: McDonald's, Brinker International, Eli Lilly
09:33pm, Monday, 29'th Apr 2024
Ari Wald, Oppenheimer head of technical analysis, joins CNBC's 'The Exchange' to discuss earnings from McDonald's, Brinker International, and Eli Lilly.
Markets Up on Tesla, Q1 Earnings; Q1 Beats After the Bell
07:11pm, Monday, 29'th Apr 2024
It's now the third straight day higher going back to Thursday of last week, and recovered from a quick drop into the red.
Eli Lilly Just Announced More Good News: Time to Buy?
01:17pm, Sunday, 28'th Apr 2024
Eli Lilly's tirzepatide aced a pair of clinical trials. The medicine's sales potential looks mouthwatering.
Forget Nvidia, These Unstoppable Stocks Are Better Buys
11:10am, Saturday, 27'th Apr 2024
Healthcare stocks can offer investors more predictable growth opportunities than artificial intelligence, where there's much more uncertainty in the long run. Eli Lilly and Novo Nordisk have top drugs
1 Unstoppable Pharmaceutical Stock Investors Shouldn't Sleep On
09:15am, Saturday, 27'th Apr 2024
Eli Lilly is the developer of GLP-1 treatments Mounjaro and Zepbound. Currently used to treat diabetes and obesity, they could have far more reach.
